Section Arrow
AZTA.NASDAQ
- Azenta
Quotes are at least 15-min delayed:2025/07/07 01:02 EDT
Last
 33.23
+0.38 (+1.16%)
Day High 
33.48 
Prev. Close
32.85 
1-M High
33.21 
Volume 
543.41K 
Bid
32.8
Ask
33.61
Day Low
31.83 
Open
32.55 
1-M Low
26.26 
Market Cap 
1.50B 
Currency USD 
P/E -- 
%Yield 0.3 
10-SMA 30.61 
20-SMA 30.16 
50-SMA 28.23 
52-W High 63.58 
52-W Low 23.91 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.55/0.99
Enterprise Value
1.56B
Balance Sheet
Book Value Per Share
37.17
Cash Flow
Cash Flow Yield
0.05
Income Statement
Total Revenue
656.32M
Operating Revenue Per Share
13.77
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
AVTRAvantor13.88-0.01-0.07%13.36PE
MBOTMicrobot Medical2.6+0.1+4.00%-- 
ALCAlcon87.78-1.52-1.70%39.69PE
XRAYDENTSPLY SIRONA16.67+0.1+0.60%-- 
COOCooper Companies (The)73.3+0.28+0.38%35.28PE
Quotes are at least 15-min delayed:2025/07/07 01:02 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.